论文信息 - Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. - 字舞流文

Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.

N. Shenoy | G. Mcmahon | J. Cherrington | C. London | J. Boucher | D. Mendel | A. Hannah | M. Rosenberg | May Chien | G. Post | C. Kollias-Baker | S. Downing | Regina Zadovoskaya